NB-UVB Therapy Safe and Effective for Some Skin Conditions

A new study has helped to establish that NB-UVB microphototherapy is a safe and effective treatment for a number of skin conditions. That study, which was published in the Turkish Journal of Medical Sciences (April, 18, 2019; 49: 595-603) looked at a population of 173 patients with vitiligo, alopecia areata, lichen simplex chronicus, palmoplantar psoriasis, and psoriais vulgaris.


Women pay more for OTC facial moisturizers than men according to new study

Women pay more than men for the same facial moisturizer products according to a new study published online ahead of print in the in the Journal of Cosmetic Dermatology (April 15, 2019). In investigating the products sold by these retailers, researchers looked for marketing cues such as language, graphical design, and container shape to determine if products were priced differently based on which gender they were geared toward.

Compounds found in ginkgo biloba may have topical antimicrobial properties

Early research from scientists at Atlanta’s Emory University shows that extracts from Ginkgo biloba tree seeds may have antibacterial properties that could help treat certain skin infections. A reference from a 16th century traditional Chinese medicine manual, the Ben Cao Gang Mu led researchers to investigate claims that the ancient tree contained chemicals that could treat skin infections.

Large Study Shows That a Popular Acne Therapy is not a Risk Factor For Depression

The popular acne drug, isotretinoin, is not a specific risk factor for depression or mood disorders as previously thought, according to a large study of more than 38,000 patients. The study, conducted by researchers at Northwestern University Feinberg School of Medicine in Chicago was presented at the 2019 American Academy of Dermatology Annual Meeting in March.

A New Study Finds That Patients With Eczema are More Likely to Have Anxiety and Depression

The risk of being diagnosed with mental health issues like anxiety and depression rises by 50 per cent for those with eczema. In Individuals without eczema, the rate is approximately 27%. This new information comes courtesy of a new study conducted by US dermatologists and allergists and published online ahead of print in the British Journal of Dermatology (March 5, 2019).